- Home
- AQST vs RMM Comparison
AQST vs RMM Comparison
Compare AQST & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RMM
- Stock Information
- Founded
- AQST 2004
- RMM 2019
- Country
- AQST United States
- RMM United States
- Employees
- AQST N/A
- RMM N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RMM Trusts Except Educational Religious and Charitable
- Sector
- AQST Health Care
- RMM Finance
- Exchange
- AQST Nasdaq
- RMM Nasdaq
- Market Cap
- AQST 285.4M
- RMM 297.3M
- IPO Year
- AQST 2018
- RMM N/A
- Fundamental
- Price
- AQST $3.01
- RMM $15.17
- Analyst Decision
- AQST Strong Buy
- RMM
- Analyst Count
- AQST 8
- RMM 0
- Target Price
- AQST $10.38
- RMM N/A
- AVG Volume (30 Days)
- AQST 2.0M
- RMM 66.5K
- Earning Date
- AQST 03-05-2025
- RMM 01-01-0001
- Dividend Yield
- AQST N/A
- RMM 7.33%
- EPS Growth
- AQST N/A
- RMM N/A
- EPS
- AQST N/A
- RMM 0.96
- Revenue
- AQST $58,900,000.00
- RMM N/A
- Revenue This Year
- AQST $18.44
- RMM N/A
- Revenue Next Year
- AQST N/A
- RMM N/A
- P/E Ratio
- AQST N/A
- RMM $15.55
- Revenue Growth
- AQST 22.56
- RMM N/A
- 52 Week Low
- AQST $2.24
- RMM $12.32
- 52 Week High
- AQST $6.23
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- AQST 43.29
- RMM 60.20
- Support Level
- AQST $2.95
- RMM $14.80
- Resistance Level
- AQST $3.21
- RMM $15.22
- Average True Range (ATR)
- AQST 0.20
- RMM 0.10
- MACD
- AQST 0.02
- RMM 0.02
- Stochastic Oscillator
- AQST 18.42
- RMM 88.10
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.